Just – Evotec Biologics brings 2 presentations to BPI 2026 in Boston, and exhibits at Booth 1029. Its contribution covers cell line development and the culture media behind it, looking at scalable platforms and osmolality measurements that guide clone selection, and at a perfusion medium formulated for CHO productivity at scale.
| Organization | BPI 2026 Attendance |
|---|---|
Just – Evotec Biologics Seattle, Washington | 1 Cell Line Development- Scientist I · 1 Associate Director, Media Development |
US-based CDMO, a wholly owned subsidiary of Evotec, developing and manufacturing complex biologics including antibodies, bi- and multispecifics, and biosimilars. | Booth Exhibiting at Booth 1029 Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 1:00pm–1:45pm Talk Thu Sep 24 10:40am–10:50am |
Instantly find 20 buyers from Just – Evotec Biologics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction